Abstract
Estrogenic compounds exert pleiotropic effects in wildlife and humans, and endogenous estrogens, like 17β-estradiol, regulate growth and development of their target tissues. Environmental, industrial, or naturally occurring chemicals that possess estrogenic and/or antiestrogenic activities are termed xenoestrogens and may interfere with endocrine systems. These xenoestrogens are therefore defined as endocrine-active or endocrine-disrupting compounds. The estrogen receptor (ER) is the major regulatory unit within the estrogen-signaling pathway and the molecular mechanisms of estrogen and ER actions are described briefly. Based on the mechanism of ER action, in vitro test systems are described that can be employed for screening but also for the elucidation of mechanisms of action of (anti)estrogenic compounds. How screening assays and mechanistic studies can aid in human risk assessment for potential endocrine-active compounds is discussed also.
Similar content being viewed by others
References
Colburn T, Clement C (1992) Chemically induced alterations in sexual and functional development: the wildlife/human connection. Princeton Scientific Publishing, Princeton
Newbold RR, McLachlan JA (1996) Transplacental hormonal carcinogenesis: diethylstilbestrol as an example. In: Huff J, Boyd J, Barrett JC (eds) Cellular and molecular mechanisms of hormonal carcinogenesis: environmental influences. Wiley-Liss, New York, pp 131–147
Tsai M-J, O’Malley B (1994) Annu Rev Biochem 63:451–486
Gray JLE, Ostby J, Wilson V, Lambright C, Bobseine K, Hartig P, Hotchkiss A, Wolf C, Furr J (2002) Toxicology 181–182:371–382
Gray LE Jr, Kelce WR, Wiese T, Tyl R, Gaido K, Cook J, Klinefelter G, Desaulniers D, Wilson E, Zacharewski T, Waller C, Foster P, Laskey J, Reel J, Giesy J, Laws S, McLachlan J, Breslin W, Cooper R, Di Giulio R, Johnson R, Purdy R, Mihaich E, Safe S, Colborn T (1997) Reprod Toxicol 11:719–750
Ashby J (2000) Toxicol Pathol 28:432–437
Mueller SO (2002) J Chromatogr B 777:155–165
Safe S, Wang F, Porter W, Duan R, McDougal A (1998) Toxicol Lett 102–103:343–347
Evans RM (1988) Science 240:889–895
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schuetz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) Cell 83:835–839
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Nature 320:134–139
Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P (1986) J Steroid Biochem 24:77–83
Kuiper GGJM, Enmark E, Pelto-Huiko M, Nilsson S, Gustafsson J (1996) Proc Natl Acad Sci USA 93:5925–5930
Mosselman S, Polman J, Dijkema R (1996) FEBS Lett 392:49–53
Couse JF, Korach KS (1999) Endocrine Rev 20:358–417
Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS (1999) Science 286:2328–2331
Mueller SO, Korach KS (2001) Curr Opin Pharmacol 1:613–619
Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies, O (1998) Proc Natl Acad Sci USA 95:15677–15682
Couse JF, Bunch DO, Lindzey J, Schomberg DW, Korach KS (1999) Endocrinology 140:5855–5865
Prins GS, Birch L, Couse JF, Cho, I, Katzenellenbogen B, Korach KS (2001) Cancer Res 61:6089–6097
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Endocrinology 139:4252–4263
Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH, Pestell RG, Kushner PJ (2002) J Biol Chem 277:24353–24360
Weihua Z, Lathe R, Warner M, Gustafsson JA (2002) Proc Natl Acad Sci USA 99:13589–13594
Hall JM, Couse JF, Korach KS (2001) J Biol Chem 276:36869–36872
Mueller SO, Korach KS (2001) Mechanisms of estrogen receptor-mediated agonistic and antagonistic effects. In: Metzler M (ed) Endocrine disruptors. Springer, Berlin Heidelberg New York, pp 1–25
Hyder SM, Chiappetta C, Stance, GM (1999) Biochem Pharmacol 57:597–601
Klinge CM (2001) Nucleic Acids Res 29:2905–2919
Ogawa S, Eng V, Taylor J, Lubahn DB, Korach KS, Pfaff DW (1998) Endocrinology 139:5070–5081
Cowley SM, Hoare S, Mosselman S, Parker MG (1997) J Biol Chem 272:19858–19862
Hall JM, McDonnell DP (1999) Endocrinology 140:5566–5578
McKenna NJ, O’ Malley BW (2002) Endocrinology 143:2461–2465
McKenna NJ, Lanz RB, O’Malley BW (1999) Endocrine Rev 20:321–344
Chen JD, Evans RM (1995) Nature 377:454–457
Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG (1995) Nature 377:397–404
Wolffe AP (1997) Cell Res 7:127–142
Gardner RM, Kirkland JL, Ireland JS, Stancel GM (1978) Endocrinology 103:1164–1172
Vasudevan N, Ogawa S, Pfaff D (2002) Physiol Rev 82:923–944
Driggers PH, Segars JH (2002) Trends Endocrinol Metab 13:422–427
Burow ME, Tang Y, CollinsBurow BM, Krajewski S, Reed JC, McLachlan JA, Beckman BS (1999) Carcinogenesis 20:2057–2061
Liu G, Schwartz JA, Brooks SC (1999) Biochem Biophys Res Commun 264:359–364
Medh RD, Thompson EB (2000) Cell Tissue Res 301:101–124
Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, Genazzani AR (2002) Endocrinology 143:2052–2061
Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR (2000) Proc Natl Acad Sci USA 97:5930–5935
Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK (2002) J Steroid Biochem Mol Biol 83:187–193
Kelly MJ, Levin ER (2001) Trends Endocrinol Metab 12:152–156
Katzenellenbogen JA, O’Malley BW, Katzenellenbogen BS (1996) Mol Endocrinol 10:119–131
O’Connor JC, Davis LG, Frame SR, Cook JC (2000) Toxicol Sci 54:338–354
Hu X, Lazar MA (2000) Trends Endocrinol Metab 11:6–10
Shupnik MA (2000) Rev Endocr Metab Disord 1:35–42
Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ (2000) Crit Rev Toxicol 30:135–196
Vinggaard AM, Nellemann C, Dalgaard M, Jorgensen EB, Andersen HR (2002) Toxicol Sci 69:344–353
Hartig PC, Bobseine KL, Britt BH, Cardon MC, Lambright CR, Wilson VS, Gray LE Jr (2002) Toxicol Sci 66:82–90
OECD (2001) Appraisal of test methods for sex hormone disrupting chemicals. In: OECD Environment Health and Safety Publications Series on Testing and Assessment No 21. Environment Directorate OECD, Paris
Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J (1997) Endocrinology 138:863–870
Bolger R, Wiese TE, Ervin K, Nestich S, Checovich W (1998) Environ Health Perspect 106:551–557
Mueller SO, Kling M, Arifin Firzani P, Mecky A, Duranti E, Shields-Botella J, Delansorne R, Broschard T, Kramer P-J (2003) Toxicol Lett 142:89–101
Shelby MD, Newbold RR, Tully D, Chae K, Davis VL (1996) Environ Health Perspect 104:1296–1300
Makela S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS (1994) Environ Health Perspect 102:572–578
McDonnell DP (1999) Trends Endocrinol Metab 10:301–311
Ramamoorthy K, Vyhlidal C, Wang F, Chen IC, Safe S, McDonnell DP, Leonard LS, Gaido KW (1997) Tox Appl Pharmacol 147(1):93–100
Breithofer A, Graumann K, Scicchitano MS, Karathanasis SK, Butt TR, Jungbauer A (1998) J Steroid Biochem Mol Biol 67:421–429
Jiang SY, Jordan VC (1992) J Natl Cancer Inst 84:580–591
Mueller SO, Hall JM, Swope DL, Pedersen LC, Korach KS (2003) J Biol Chem 278:12255–12262
Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, van der Burg B (1999) Toxicol Sci 48:55–66
Rogers JM, Denison MS (2000) In Vitro Mol Toxicol 13:67–82
Mueller SO, Korach KS (2001) J Androl 22:652–664
Mak P, Cruz FD, Chen S (1999) Environ Health Perspect 107:855–860
Pelissero C, Lenczowski MJ, Chinzi D, Davail-Cuisset B, Sumpter JP, Fostier A (1996) J Steroid Biochem Mol Biol 57:215–223
Gray LE (1998) Toxicol Lett 103:677–680
Laskey JW, Berman E, Ferrell JM (1995) Reprod Toxicol 9:131–141
Zhou G, Cummings R, Li Y, Mitra S, Wilkinson HA, Elbrecht A, Hermes JD, Schaeffer JM, Smith RG, Moller DE (1998) Mol Endocrinol 12:1594–1604
Routledge EJ, White R, Parker MG, Sumpter JP (2000) J Biol Chem 275:35986–35993
Jorgensen M, Vendelbo B, Skakkebaek NE, Leffers H (2000) Environ Health Perspect 108:403–412
An JP, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC (2001) J Biol Chem 276:17808–17814
Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO (1995) Environ Health Perspect 103:113–122
Nikov GN, Hopkins NE, Boue S, Alworth WL (2000) Environ Health Perspect 108:867–872
Boyer M, Poujol N, Margeat E, Royer CA (2000) Nucleic Acids Res 28:2494–2502
Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA (1999) Mol Carcinog 24:153–159
Holinka CF, Hata H, Kuramoto H, Gurpide E (1986) Cancer Res 46:2771–2774
Sanderson JT, Boerma J, Lansbergen GWA, van den Berg M (2002) Tox Appl Pharmacol 182:44–54
Ando S, Sirianni R, Forastieri P, Casaburi I, Lanzino M, Rago V, Giordano F, Giordano C, Carpino A, Pezzi V (2001) Mol Cell Endocrinol 178:11–21
Acknowledgments
The author wishes to thank members of the Institute of Toxicology at Merck KGaA for fruitful discussion and comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mueller, S.O. Xenoestrogens: mechanisms of action and detection methods. Anal Bioanal Chem 378, 582–587 (2004). https://doi.org/10.1007/s00216-003-2238-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-003-2238-x